Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |